Sideinnhold
A -
B -
C -
D -
E -
F -
G -
H -
I -
J -
K -
L -
M -
N -
O -
P -
Q -
R -
S -
T -
U -
V -
X -
Y -
Z
| Lamzede (S) | velmanase alfa | alfa- mannosidose | 2018 |
|---|
| insulin glargin | Diabetes type 1 | 2009 |
|---|
| Lantus | insulin glargin | Diabetes type 2 | 2012 |
|---|
| Lartruvo (S) | olaratumab | Bløtvevssarkom | 2018 |
|---|
| Latuda | lurasidon | Schizofreni | 2015 |
|---|
Lemtrada (S)
| teriflunomid | Multippel sklerose | 2014 |
|---|
| Lenvima | lenvatinib | Thyroideakarsinom | 2016 |
|---|
| Lenvima (S) | lenvatinib | Leverkreft | 2019 |
|---|
| insulin detemir | Diabetes type 1 | 2008 |
|---|
| insulin detemir | Diabetes type 2 | 2010 |
|---|
| Levopidon (S) | levometadon | Opioidavhengighet | 2019 |
|---|
| Lixania | edokasban | Slagprofylakse, tromboseprofylakse, DVT, LE | 2016 |
|---|
| Lokelma | natrium zirkoniumsyklosilikat | Hyperkalemi ved nyresvikt | 2019 |
|---|
| Lonquex | lipegfilgrastim | Nøytropeni | 2015 |
|---|
| ranibizumab | Våt AMD | 2012 |
|---|
| Lumigan | bimatoprost | Glaukom | 2013 |
|---|
| Lynparza (S) | olaparib | Ovariekreft | 2015 |
|---|
| Lyxumia | lixisenatide | Diabetes type 2 | 2014 |
|---|
